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OBJECTIVES: To evaluate pulmonary function in the first and third trimesters of pregnancy and analyze the
influence of parity and smoking on spirometry parameters.
METHODS: This longitudinal prospective study included a cohort of 120 pregnant women. The inclusion criteria
were as follows: singleton pregnancy, gestational age less than 13.86 weeks, and no preexisting maternal
diseases. The exclusion criteria were as follows: change of address, abortion, and inadequate spirometry testing.
ClinicalTrials.gov: NCT02807038.
RESULTS: A decrease in values of forced vital capacity and forced expiratory volume were noted in the first
second from the first to third trimester. In the first and third trimesters, multiparous women demonstrated
lower absolute forced vital capacity and forced expiratory volume values in the first second compared with
nulliparous women (po0.0001 and p=0.001, respectively). Multiparous women demonstrated reduced forced
expiratory flow in 25% to 75% of the maneuver compared with nulliparous women in the first (p=0.005) and
third (p=0.031) trimesters. The absolute values of forced expiratory flow in 25% to 75%, forced expiratory
volume in the first second and predicted peak expiratory flow values in the third trimester were higher in
smokers compared with nonsmokers (p=0.042, p=0.039, p=0.024, and p=0.021, respectively).
CONCLUSION: There was a significant reduction in forced vital capacity and forced expiratory volume values in
the first second during pregnancy. Parity and smoking significantly influence spirometric variables.
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’ INTRODUCTION
Pregnancy is a period during which the female body under-
goes functional and anatomical alterations, including changes
in lung function. These findings can be assessed by spirometry,
a simple, inexpensive, and effective method (1,2).
There is some controversy regarding the results of spiro-
metry in pregnancy, particularly in terms of tobacco use and
parity. Several studies measured lung function during pregnancy
and after delivery. Mixed results have been reported for forced
vital capacity (FVC), forced expiratory volume in the first second
(FEV1), and the FEV1/FVC ratio with respect to whether they
remain the same, increase, or decrease slightly (1,3,4).
The predictors for decreasing lung function during preg-
nancy remain unknown. Multiparity and smoking status
may be associated with decreased lung function.
Objectives
This study aimed to use spirometry to evaluate changes in
pulmonary function in pregnant women between the first (T1)
and third trimester (T3) of pregnancy and to evaluate the
influence of smoking and parity during this period.
’ METHODS
This longitudinal prospective study was conducted from
August 2011 to May 2013 at the University of São Paulo
Medical School (FMUSP), Brazil. This study was approvedDOI: 10.6061/clinics/2017(10)02
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by the Ethics Committee for Research Project Analysis at the
Hospital of the Faculty of Medicine under number 193/11,
and written informed consent was obtained from the sub-
jects. ClinicalTrials.gov: NCT02807038.
Study population
We included 220 pregnant women who were consecutively
recruited from the three primary care units located in the
west of the city of São Paulo. The women were part of a
larger cohort of 400 patients who were recruited to study the
effects of environmental air pollution on pregnancy.
The following inclusion criteria were applied: receipt of
prior informed consent, singleton pregnancy, gestational age
of less than 13.86 weeks at the first evaluation, and absence
of preexisting maternal diseases. The exclusion criteria included
withdrawal from the project, abortion, and inadequate spirom-
etry testing performed at T1 and T3.
Study design
After the confirmation of pregnancy, community health
workers made the first contact with the pregnant women.
During this first meeting, the research project was explained
to the pregnant women, who were invited to participate
in the study and provide informed consent. If the women
agreed to participate, they received a card with the first assess-
ment date and information about spirometry.
The measurement techniques and spirometry parameters
were selected in accordance with the Guidelines for Pul-
monary Function Test of the Brazilian Thoracic Association (5).
All spirometric values were adjusted according to sex, age,
height, and weight at the time of the exam to estimate the
predicted values (6).
At the first assessment, the patients were asked about
previous pregnancies and tobacco use during pregnancy
according to the questionnaire in the guideline cited above.
Statistical analysis
For the characterization and summary of the study vari-
ables, the mean and standard deviation and median, mini-
mum andmaximum values were used for quantitative variables,
and absolute and relative frequency were used for qualitative
variables.
A paired t-test was used for comparison of spirometric
variables in the first and third trimesters. The t-test was
applied to compare the groups of nulliparous and multi-
parous women in relation to spirometric variables in each
trimesters, and the Mann-Whitney-test was used for compar-
ing smokers and nonsmokers.
’ RESULTS
The initial sample included 220 patients. In total, 11.4%
of the patients were excluded due to abortion, 12.7% were
excluded due to loss to follow-up, and 22% were excluded
due to unsatisfactory spirometric test results. The final sample
consisted of 120 pregnant women with 240 valid spirometric
exams. The maternal characteristics are presented in Table 1.
We analyzed the mean BMI in the first and third trimesters in
the two groups, with no significant difference found (first
trimester: nulliparous=25.65±5.02; multiparous=26.75±5.81
p=0.273); (third trimester: nulliparous=28.70±4.73, multiparous=
29.55±5.84 p=0.390). There also was no significant difference
in the percentage of obese patients in the two groups studied
(nulliparous=11/54 (20.4%), multiparous=13/66 (19.7%) p=0.927).
Table 2 presents the spirometric values obtained in T1 and
T3. The absolute and relative values of FVC and absolute
and % predicted values of FEV1 were significantly reduced in
T3 compared with T1.
In terms of parity, as shown in Table 3, 54 patients (45%)
were nulliparous, and the other 66 patients (55%) were
multiparous. In T1, the multiparous women (0.816±0.059)
had smaller FEV1/FVC ratios compared with the nulliparous
women (0.863±0.049) (po0.0001) and smaller forced expira-
tory flow in 25% to 75% (FEF25-75%), at p=0.005 (multiparous
women (3.207±0.911) and nulliparous women (3.657±0.797)).
In T3, the multiparous women exhibited reductions in the
same parameters compared with the nulliparous women:
FEV1/FVC (multiparous women (30.827±0.047) and nulli-
parous women (0.856±0.047)) and FEF25-75% (multiparous
women (3.253±0.788) and nulliparous women (3.558±
0.727)) (p=0.00.1 and p=0.031, respectively). Maternal age
differed among nulliparous (23.00±5.57) and multiparous
(29.17±5.96) women at pp0.001. To eliminate the confound-
ing effect of age on absolute spirometry results, patients were
categorized according to age: less or equal to 25 and more than
25 years age (Table 4).
Regarding smoking, as shown in Table 5, 17 of the 120 (14.17%)
women smoked one to ten cigarettes a day throughout their
pregnancies. Some parameters were significantly higher in
nonsmokers compared with smokers.
Smokers had lower absolute values of FVC in T1 (3.48±
0.37) when compared to nonsmokers (3.70±0.47), p=0.042
lower absolute values of FEV1 in T3 (2.78±0.29) when com-
pared to nonsmokers (2.99±0.39), p=0.039 lower absolute
values of FEF25-75% in T3 (3.00±0.69) when compared to non-
smokers (3.46±0.76), p=0.024 and lower values of predicted
peak expiratory flow (PEF) in T3 (smokers (71.71±11.39) and
nonsmokers (80.36±12.53), p=0.021.
’ DISCUSSION
In this study, it was possible to evaluate the spirometry
results of 120 pregnant women during the first and third
trimesters of pregnancy. In addition, the results were com-
pared according to parity and smoking. Spirometry is the
most widely used pulmonary function test, although it is
estimated that approximately 15% of spirometry tests are
inadequate (7,8). Because we required two complete exam-
inations (i.e., in T1 and T3), some patients were excluded
(22%). However, in one study of the long-term effect of air
pollution on respiratory health in adult Swiss woman (9),
a 28% loss to follow-up (related to inadequate spirometry
tests) was reported, which was greater than the loss during
follow-up in the current study.
All spirometric values in the pregnant subjects were within
normal ranges. The FVC and FEV1 values decreased signifi-
cantly in the third trimester. Redivo (10) described no changes
in pulmonary function in pregnancy (10); however, Grindheim
et al. (7) demonstrated differences, particularly in FVC and
PEF (7). The results of recent studies agree with our find-
ings (1,11). These reduced values may be due to decreased
negative intrapleural pressure due to an upward tilt of the
diaphragm caused by the enlarging uterus. Another expla-
nation is the reduction in the alveolar partial pressure
of carbon gas, which is caused by hyperventilation during
pregnancy (12).
Our results also revealed differences in the spirometric
values between smokers and nonsmokers and nulliparous
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and multiparous women. Compared with the nulliparous
women, the multiparous pregnant women had significantly
reduced absolute values of FEV1/FVC and FEF25-75%. This
reduction was maintained among the younger multiparous
women (p25 years age) when compared to the younger
nulliparous women, suggesting that the decrease found is
due to parity. In relation to multiparous women who are
more than 25 years old, only the FEV1/FVC ratio in T1
maintained a significant effect. It is important to consider
that for this analysis, there was a significant decrease in
the number of patients in each group, which can directly
influence the calculation of the p value. It can be observed
that the average of these spirometric variables for different
age groups remained similar to the general analysis.
The % predicted value of FEV1/FVC and FEF25-75%., which
took into account individual characteristics (sex, age, and
body mass index), was not significantly different between
the two groups. Grindheim et al. (7) found similar results in
Table 1 - Maternal characteristics.
Mean±SD
Age (years) 26.39±6.54
Height (meters) 1.60±0.06
Weight (kg) T1= 68.55±13.86
T3 = 75.97±12.86
Gestational age (weeks) T1 = 10.60±1.80
T3 = 31.70±0.80
Ethnicity White 38 (31.17%)
Brown 66 (55.00%)
Black 16 (13.33%)
Marital status Single 39 (32.50%)
Married 44 (36.67%)
Cohabitating 35 (29.17%)
Separated 2 (1.67%)
Education level Incomplete primary education 30 (25.00%)
Complete primary education 9 (7.5%)
Incomplete secondary education 21 (17.50%)
High school 47 (39.17%)
Incomplete higher education 4 (3.33%)
University graduates 9 (7.50%)
Occupation Housewife 35 (29.2%)
Housemaid 9 (7.5%)
General Services Assistant 7 (5.8%)
Hairdresser/Manicurist 5 (4.2%)
Unemployed 8 (6.7%)
Other 56 (46.6%)
Monthly income (Minimum wage (MW): $ 34,700) Less than half MW 1 (0.80%)
Half to equal to one MW 13 (10.80%)
Between one and three times MW 68 (56.70%)
Between three and five times MW 15 (12.50%)
Could not inform 6 (5.00%)
Would not inform 17 (14.20%)
Exclusions Abortion 25 (11.14%)
Discontinued participation 18 (8.20%)
Change of address 10 (4.50%)
Inappropriate spirometry test 48 (21.80%)
Table 2 - Comparison of spirometric variables between the first and third trimesters of pregnancy.
Variable T1 T3 Sig (p)
Mean±SD Mean±SD
Absolute values FVC 3.670±0.467 3.532±0.459 o0.001
FEV1 3.070±0.397 2.964±0.387 o0.001
FEV1/FVC 0.837±0.059 0.840±0.049 0.486
FEF25-75% 3.409±0.887 3.390±0.773 0.667
PEF 6.179±1.113 6.042±0.964 0.044
% predicted values FVC 101.31±10.352 97.20±10.694 o0.001
FEV1 99.43±10.880 95.90±11.040 o0.001
FEV1/FVC 97.02±6.563 97.53±6.075 0.212
FEF25-75% 96.00±24.961 95.80±23.624 0.881
PEF 80.63±14.918 79.23±12.800 0.142
paired t-test.
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their study, which analyzed a cohort of 87 healthy pregnant
women. The authors concluded that the predicted FVC
values in multiparous pregnant women decreased by 4.4%
compared with those in nulliparous women (p=0.039).
No statistically significant differences were observed in the
absolute and predicted PEF values. Although obesity was
related to changes in spirometry and also to multiparity,
there was no difference between the groups in relation to this
maternal characteristic.
The absolute values of FVC, FEF25-75%, and FEV1 were
significantly decreased in smokers compared with nonsmokers.
Vergara et al. (13) studied lung function in 136 girls (45.5%) in
relation to smoking (active and passive smokers) and investi-
gated repercussions on spirometric parameters. A significant
association was found between smoking and spirometric para-
meters (ANOVA), which was lower in smokers: FVC (p=0.001),
FEV1 (p=0.0001), FEV1/FVC (p=0.004), PEF (p=0.0001), and
FEF25-75% (p=0.0001).
Prasad et al. (14) reported a study involving over 100
female smokers and 100 female non-smokers in the age
group of 30-40 years in which three lung function tests, FEVI,
FVC and PEFR, were employed, and it was observed that all
parameters of the three lung function tests were significantly
reduced among the smokers compared to the non-smokers.
Table 3 - Comparison of spirometric variables in the first and third trimesters between nulliparous and multiparous women.
Variable Nulliparous (n=54) Multiparous (n=66) Sig (p)
T Mean±SD Median (Min - Max) Mean±SD Median (Min - Max)
Absolute FVC 1 3.645±0.537 3.67 (2.65 - 4.89) 3.688±0.400 3.70 (2.89 - 4.70) 0.646
3 3.531 ±0.509 3.57 (2.67 - 5.00) 3.533 ±0.416 3.49 (2.72 - 4.89) 0.979
FEV1 1 3.142±0.419 3.18 (2.29 - 4.07) 3.010±0.317 2.97 (2.15 - 4.12) 0.071
3 3.015 ±0.407 3.01 (2.24 - 4.00) 2.923 ±0.367 2.91 (2.12 - 4.05) 0.196
FEV1/FVC 1 0.863±0.049 0.87 (0.75 - 0.96) 0.816±0.059 0.82 (0.70 - 0.97) o0.0001
3 0.856 ±0.047 0.85 (0.75 - 0.98) 0.827 ±0.047 0.84 (0.72 - 0.96) 0.001
FEF25-75% 1 3.657±0.797 3.71 (2.10 - 5.29) 3.207±0.911 3.24 (1.63 - 5.79) 0.005
3 3.558 ±0.727 3.59 (1.96 - 5.33) 3.253 ±0.788 3.26 (1.54 - 4.84) 0.031
PEF 1 6.346±1.176 6.17 (3.87 - 9.40) 6.043±1.049 6.07 (3.78 - 9.76) 0.140
3 6.137 ±1.032 6.30 (3.77 - 8.84) 5.965 ±0.905 6.12 (3.72 - 9.06) 0.330
% predicted values FVC 1 101.48±11.881 101.00 (79 - 126.00) 101.17±9.002 101.50 (83.00 - 123.00) 0.873
3 98.00 ±12.349 97 (74.00 - 128.00) 96.55 ±9.169 98.00 (75.00 - 121.00) 0.474
FEV1 1 101.57±11.661 102.00 (80.00 - 130.00) 97.68±9.945 98.50 (78.00 - 121.00) 0.051
3 97.43 ±11.721 97.00 (75.00 - 125.00) 94.65 ±10.374 95.00 (73.00 - 122.00) 0.172
FEV1/FVC 1 98.22±5.784 99.00 (84.00 - 108.00) 96.03±7.027 96.00 (83.00 - 116.00) 0.069
3 97.52 ±6.433 99.00 (83.00 - 107.00) 97.55 ±5.816 98.50 (85.00 - 114.00) 0.981
FEF25-75% 1 99.46±22.094 98.00 (51.00 - 161.00) 93.17±26.918 90.00 (53.00 - 173.00) 0.170
3 96.59 ±21.913 98.50 (46.00 - 151.00) 95.15 ±25.085 94.00 (50.00 - 150.00) 0.741
PEF 1 83.22±14.392 82.00 (50.00 - 114.00) 78.90±15.014 80.00 (49.00 - 127.00) 0.152
3 80.61 ±11.794 81.00 (51.00 - 108.00) 78.21 ±13.263 79.00 (48.00 - 117.00) 0.352
Table 4 - Comparison of spirometric variables in the first and third trimesters between nulliparous and multiparous women at p 25
and 4 25 years old.
Variable T Women p25 years sig (p) Women 425 years sig (p)
Nulliparous (n=40) Multiparous (n=20) Nulliparous (n=14) Multiparous (n=46)
Mean±SD Mean±SD Mean±SD Mean±SD
Absolute FVC 1 3.626±0.532 3.670±0.315 0.691 3.712±0.569 3.696±0.436 0.910
3 3.515±0.493 3.516±0.318 0.993 3.579±0.573 3.542±0.456 0.801
FEV1 1 3.143±0.419 3.038±0.265 0.310 3.141±0.438 2.999±0.412 0.269
3 3.016±0.411 2.911±0.269 0.302 3.014±0.412 2.928±0.409 0.499
FEV1/FVC 1 0.870±0.053 0.829±0.054 0.007 0.847±0.032 0.812±0.062 0.043
3 0.860±0.050 0.830±0.045 0.026 0.845±0.036 0.826±0.049 0.185
FEF25-75% 1 3.721±0.825 3.230±0.673 0.025 3.474±0.707 3.197±1.004 0.342
3 3.564±0.755 3.220±0.650 0.088 3.542±0.667 3.268±0.849 0.273
PEF 1 6.292±0.987 6.169±1.125 0.666 6.502±1.639 5.989±1.023 0.284
3 6.121±1.088 5.762±0.911 0.210 6.185±0.892 6.052±0.899 0.630
% predicted values FVC 1 101.250±10.970 99.800±7.031 0.538 101.143±14.623 101.761±9.746 0.928
3 97.450±11.031 94.450±7.577 0.223 99.571±15.907 97.457±9.715 0.644
FEV01 1 101.050±10.651 96.050±7.715 0.065 103.071±14.715 98.391±10.771 0.198
3 96.625±10.860 91.300±7.349 0.053 99.571±14.095 96.109±11.202 0.325
FEV1/FVC 1 97.375±6.270 94.350±5.613 0.074 100.643±3.153 96.761±7.499 0.007
3 96.475±6.752 95.300±5.516 0.504 100.500±11.202 98.522±5.726 0.239
FEF25-75% 1 96.950±22.368 83.150±18.082 0.020 106.643±20.353 97.522±29.061 0.279
3 92.450±20.551 82.750±17.235 0.075 108.429±22.065 100.543±26.181 0.312
PEF 1 81.929±11.857 75.867±14.202 0.144 86.000±19.022 79.911±15.294 0.273
3 80.111±13.195 71.063±11.710 0.029 81.571±8.847 80.756±12.958 0.827
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One limitation is the fact that smoking research was per-
formed only through a structured questionnaire with the
possibility of one response (yes or no). Currently, the use of
monoximetry is suggested to more accurately discriminate
smokers who, for any reason, will declare themselves to be
non-smokers. Nonetheless, we must point out that the great
majority of studies in the literature that use spirometry for
lung function evaluation do not advocate the performance
of monoximetry to exclude smoking. In this study, we
concluded that the absolute values of FVC, FEF25-75%, and
FEV1 were significantly decreased in smokers compared with
nonsmokers, with significant reductions in absolute and in %
predicted FVC and FEV1 values during pregnancy (T1 to T3).
Parity and smoking significantly influenced spirometric para-
meters, and these are important factors that must be considered
when analyzing spirometry results during pregnancy.
FVC and FEV1 values decreased significantly in the third
trimester. The reductions in these parameters may be explained
by the upward tilt of the diaphragm caused by the enlarging
uterus, causing a decreased negative intrapleural pressure, and
because of a reduction in the alveolar partial pressure of carbon
gas, which is caused by hyperventilation during pregnancy.
Decreased lung function at both the beginning and end of the
gestational period is more evident in multiparous women and
those who smoke.
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3 2.99±0.39 2.95 (2.12 - 4.05) 2.78±0.29 2.84 (2.12 - 4.05) 0.039
FEV1/FVC 1 0.84±0.06 0.84 (0.70 - 0.97) 0.84±0.05 0.84 (0.71 - 0.96) 0.842
3 0.84±0.04 0.84 (0.73 - 0.98) 0.83±0.05 0.83 (0.72 - 0.95) 0.154
FEF25-75% 1 3.44±0.90 3.43 (1.63 - 5.59) 3.22±0.75 3.26 (1.63 - 4.21) 0.447
3 3.46±0.76 3.42 (1.55 - 5.33) 3.00±0.69 3.07 (1.54 - 4.09) 0.024
PEF 1 6.25±1.14 6.22 (3.78 - 9.76) 5.73±0.81 5.92 (4.02 - 7.24) 0.055
3 6.11±0.96 6.20 (3.72 - 9.06) 5.65±0.85 5.58 (3.89 - 6.83) 0.078
% predicted values FVC 1 101.95±10.67 102 (79 - 126) 97.41±7.15 96 (87 - 110) 0.064
3 97.78±11.00 98 (78 - 128) 93.71±7.92 94 (78 - 111) 0.131
FEV1 1 100.07±11.11 100 (78 - 130) 95.59±7.63 99 (80 - 108) 0.144
3 96.70±11.10 96 (73 - 125) 91.06±9.53 95 (75 - 106) 0.081
FEV1/FVC 1 97.02±6.62 97 (83 - 116) 97.00±6.39 99 (85 - 105) 0.734
3 97.79±6.09 99 (83 - 114) 96.00±5.88 97 (85 - 103) 0.252
FEF25-75% 1 96.86±25.15 94 (51 - 173) 90.76±23.79 93 (53 - 156) 0.416
3 97.43±23.54 98 (50 - 151) 85.94±22.30 93 (46 - 135) 0.076
PEF 1 81.63±15.02 82 (49 - 127) 84.57±12.47 78 (50 - 97) 0.092
3 80.36±12.53 80 (48 - 117) 71.71±11.39 70 (51 - 88) 0.021
Mann-Whitney U-test.
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